The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and preliminary efficacy of YK-029A, a novel EGFR TKI, in patients with advanced NSCLC harboring ex20ins, T790M or rare mutations.
 
Jianchun Duan
No Relationships to Disclose
 
Jun Zhao
No Relationships to Disclose
 
Li Zhang
No Relationships to Disclose
 
Baogang Liu
No Relationships to Disclose
 
Xiubao Ren
No Relationships to Disclose
 
Mingjun Li
No Relationships to Disclose
 
Bo Shen
No Relationships to Disclose
 
Liyun Miao
No Relationships to Disclose
 
Xiumei Dai
No Relationships to Disclose
 
Yueyin Pan
No Relationships to Disclose
 
Yupin Li
No Relationships to Disclose
 
Yu Yao
No Relationships to Disclose
 
Kunyu Yang
No Relationships to Disclose
 
Lin Wu
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Hengrui Pharmaceutical; Innovent Biologics; Lilly; Merck; MSD; Pfizer; Roche
 
Chengzhi Zhou
No Relationships to Disclose
 
Qitao Yu
No Relationships to Disclose
 
Yanyan Xie
No Relationships to Disclose
 
Shan Zeng
No Relationships to Disclose
 
Jie Wang
No Relationships to Disclose